Spontaneous remission without progression to limbic encephalitis in a patient with LGi1 seropositive faciobrachial dystonic seizure
Faciobrachial dystonic seizures are pathognomonic of leucine-rich glioma inactivated-1 (LGi1) antibody, non-paraneoplastic limbic encephalitis. Faciobrachial dystonic seizures usually precede limbic encephalitis by about a month. It is unknown whether, if untreated, faciobrachial dystonic seizures i...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Published: |
ASEAN Neurological Association
2016
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/18135/ https://www.neurology-asia.org/articles/neuroasia-2016-21(2)-191.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Faciobrachial dystonic seizures are pathognomonic of leucine-rich glioma inactivated-1 (LGi1) antibody, non-paraneoplastic limbic encephalitis. Faciobrachial dystonic seizures usually precede limbic encephalitis by about a month. It is unknown whether, if untreated, faciobrachial dystonic seizures inevitably progress to limbic encephalitis. We present an LGi1 seropositive patient with a year’s history of faciobrachial dystonic seizures, who achieved remission spontaneously without immunotherapy or antiepileptic drug treatment, and did not develop evidence of limbic encephalitis over a three-year follow-up. |
|---|